NEW CLASS OF RX FLU DRUGS IS SET

RESEARCH TRIANGLE PARK, N.C. -- The first in a new generation of prescription influenza medications -- a class called neuraminidase inhibitors -- will hit supermarket pharmacies following U.S. Food and Drug Administration approval last month. Competition for the new drug may not be far behind.Relenza, produced by Glaxo Wellcome Inc., based here, is an inhaled form of the anti-flu agent zanamivir.

RESEARCH TRIANGLE PARK, N.C. -- The first in a new generation of prescription influenza medications -- a class called neuraminidase inhibitors -- will hit supermarket pharmacies following U.S. Food and Drug Administration approval last month. Competition for the new drug may not be far behind.

Register to view the full article